Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: A phase III, randomized trial in adults aged ≥18 years

Kieninger D.Sheldon E.Lin W.-Y.CHONG-JEN YUBayas J.M.Gabor J.J.Esen M.Fernandez Roure J.L.Narejos Perez S.Alvarez Sanchez C.Feng Y.Claeys C.Peeters M.Innis B.L.Jain V.2022-06-272022-06-2720131471-2334https://www.scopus.com/inward/record.uri?eid=2-s2.0-84880343989&doi=10.1186%2f1471-2334-13-343&partnerID=40&md5=a6ec736adb36d55a424c10e4b46a6820https://scholars.lib.ntu.edu.tw/handle/123456789/614230[SDGs]SDG3Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: A phase III, randomized trial in adults aged ≥18 yearsjournal article10.1186/1471-2334-13-343238831862-s2.0-84880343989